NEW YORK (Standard&Poor's) Feb. 5, 2014--Standard&Poor's Ratings Services said today that CVS Caremark Corp.'s announcement that it will stop selling cigarettes and tobacco products as of Oct. 1, 2014 , does not have an impact on our rating on the company (BBB+/Stable/A-2). Although we expect an annual revenue loss of about $2.0 billion, the impact on the retail segment's operating profit is expected to be modest given identified opportunities to offset profit loss. As such, we expect CVS Caremark to maintain an "intermediate" financial risk profile.